SS-31

A mitochondria-targeted peptide (also known as Elamipretide) that binds to cardiolipin, a phospholipid essential for energy production in the inner mitochondrial membrane. SS-31 supports mitochondrial function, cellular energy (ATP) production, and protection against oxidative stress.

Subcutaneous injection, per a physician-determined protocol. Typical cycles run 8–12 weeks. Your provider will walk you through dosing, timing, and injection technique.

Adults focused on cognitive performance, sustained energy, and longevity — particularly those experiencing mental fatigue, declining energy, or who prioritize cellular-level aging support. Often chosen by individuals optimizing healthspan.

May not be appropriate for individuals who are pregnant or nursing, have active malignancy, or have certain chronic medical conditions. A prescribing provider would review your full medical history, current medications, and any relevant lab results before recommending a protocol.

Generally well tolerated, with possible injection-site reactions, mild headache, or fatigue during the initial cycle. Rare but more serious risks include allergic reactions. A prescribing provider would review benefits, risks, and monitoring requirements before starting.

Yes — SS-31 is often used alongside other cellular-health and longevity-focused protocols. Combinations should always be coordinated with a prescribing provider to ensure appropriate timing and avoid interactions.